Tenaya Therapeutics, Inc.

Historical 13F Holders

Symbol
TNYA
CUSIP
87990A106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 87990A106 since 12/18/2024, largest first.

Filer % of Class Filed
Column Group III, LP 13D/A
23.1% 2/26/2026
Event 2/25/2026
Column Group Opportunity III, LP 13D/A
21.6% 11/16/2026
Event 9/30/2026
Integrated Core Strategies (US) LLC 13G
5.2% 8/24/2026
Event 8/17/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Woodline Partners LP 13G/A 4.99% 8/14/2025
Event 6/30/2025
Empery Asset Management, LP 13G/A
4.99% 7/31/2025
Event 6/30/2025
Casdin Capital, LLC 13D/A
4.3% 3/7/2025
Event 3/4/2025
JPMorgan Chase & Co 13G/A 2.8% 3/6/2025
Event 2/28/2025
BlackRock, Inc. 13G/A 1.7% 7/16/2025
Event 6/30/2025
RA Capital Management, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 98 51.2 M $30.9M
2026 Q2 101 53.7 M $39.7M
2026 Q1 103 56.3 M $38.9M
2025 Q4 98 68.7 M $48.9M
2025 Q3 92 34.5 M $55.5M
2025 Q2 90 31.5 M $19.2M
2025 Q1 109 48.6 M $27.7M
2024 Q4 89 44.0 M $62.8M
2024 Q3 96 57.6 M $111M
2024 Q2 97 57.1 M $177M
2024 Q1 91 56.0 M $293M
2023 Q4 75 46.7 M $151M
2023 Q3 78 49.7 M $127M
2023 Q2 80 47.7 M $280M
2023 Q1 66 45.0 M $128M
2022 Q4 69 47.1 M $94.7M
2022 Q3 74 35.2 M $102M
2022 Q2 52 37.1 M $209M
2022 Q1 51 37.3 M $440M
2021 Q4 48 35.4 M $668M
2021 Q3 48 33.9 M $693M